190 related articles for article (PubMed ID: 25719894)
21. Kennedy's disease: clinical significance of tandem repeats in the androgen receptor.
Zajac JD; Fui MN
Adv Exp Med Biol; 2012; 769():153-68. PubMed ID: 23560310
[TBL] [Abstract][Full Text] [Related]
22. Onset Manifestations of Spinal and Bulbar Muscular Atrophy (Kennedy's Disease).
Finsterer J; Soraru G
J Mol Neurosci; 2016 Mar; 58(3):321-9. PubMed ID: 26482145
[TBL] [Abstract][Full Text] [Related]
23. Morphological changes of skeletal muscle in spinal and bulbar muscular atrophy (SBMA), Kennedy's disease: a case report.
Acewicz A; Wierzba-Bobrowicz T; Lewandowska E; Sienkiewicz-Jarosz H; Sulek A; Antczak J; Rakowicz M; Ryglewicz D
Clin Neuropathol; 2015; 34(4):199-206. PubMed ID: 25828775
[TBL] [Abstract][Full Text] [Related]
24. ClC-2-like Chloride Current Alterations in a Cell Model of Spinal and Bulbar Muscular Atrophy, a Polyglutamine Disease.
Martínez-Rojas VA; Jiménez-Garduño AM; Michelatti D; Tosatto L; Marchioretto M; Arosio D; Basso M; Pennuto M; Musio C
J Mol Neurosci; 2021 Mar; 71(3):662-674. PubMed ID: 32856205
[TBL] [Abstract][Full Text] [Related]
25. Contractile dysfunction in muscle may underlie androgen-dependent motor dysfunction in spinal bulbar muscular atrophy.
Oki K; Halievski K; Vicente L; Xu Y; Zeolla D; Poort J; Katsuno M; Adachi H; Sobue G; Wiseman RW; Breedlove SM; Jordan CL
J Appl Physiol (1985); 2015 Apr; 118(7):941-52. PubMed ID: 25663674
[TBL] [Abstract][Full Text] [Related]
26. MEF2 impairment underlies skeletal muscle atrophy in polyglutamine disease.
Nath SR; Lieberman ML; Yu Z; Marchioretti C; Jones ST; Danby ECE; Van Pelt KM; Sorarù G; Robins DM; Bates GP; Pennuto M; Lieberman AP
Acta Neuropathol; 2020 Jul; 140(1):63-80. PubMed ID: 32306066
[TBL] [Abstract][Full Text] [Related]
27. Cerebral involvement in spinal and bulbar muscular atrophy (Kennedy's disease): a pilot study of PET.
Lai TH; Liu RS; Yang BH; Wang PS; Lin KP; Lee YC; Soong BW
J Neurol Sci; 2013 Dec; 335(1-2):139-44. PubMed ID: 24120273
[TBL] [Abstract][Full Text] [Related]
28. Polymorphic CAG repeat length in the androgen receptor gene and association with neurodegeneration in a heterozygous female carrier of Kennedy's disease.
Greenland KJ; Beilin J; Castro J; Varghese PN; Zajac JD
J Neurol; 2004 Jan; 251(1):35-41. PubMed ID: 14999487
[TBL] [Abstract][Full Text] [Related]
29. The Role of the Protein Quality Control System in SBMA.
Rusmini P; Crippa V; Cristofani R; Rinaldi C; Cicardi ME; Galbiati M; Carra S; Malik B; Greensmith L; Poletti A
J Mol Neurosci; 2016 Mar; 58(3):348-64. PubMed ID: 26572535
[TBL] [Abstract][Full Text] [Related]
30. The French national protocol for Kennedy's disease (SBMA): consensus diagnostic and management recommendations.
Pradat PF; Bernard E; Corcia P; Couratier P; Jublanc C; Querin G; Morélot Panzini C; Salachas F; Vial C; Wahbi K; Bede P; Desnuelle C;
Orphanet J Rare Dis; 2020 Apr; 15(1):90. PubMed ID: 32276665
[TBL] [Abstract][Full Text] [Related]
31. Silencing neuronal mutant androgen receptor in a mouse model of spinal and bulbar muscular atrophy.
Sahashi K; Katsuno M; Hung G; Adachi H; Kondo N; Nakatsuji H; Tohnai G; Iida M; Bennett CF; Sobue G
Hum Mol Genet; 2015 Nov; 24(21):5985-94. PubMed ID: 26231218
[TBL] [Abstract][Full Text] [Related]
32. Role of androgen receptor polyQ chain elongation in Kennedy's disease and use of natural osmolytes as potential therapeutic targets.
Kumar R
IUBMB Life; 2012 Nov; 64(11):879-84. PubMed ID: 23024039
[TBL] [Abstract][Full Text] [Related]
33. Beyond motor neurons: expanding the clinical spectrum in Kennedy's disease.
Manzano R; Sorarú G; Grunseich C; Fratta P; Zuccaro E; Pennuto M; Rinaldi C
J Neurol Neurosurg Psychiatry; 2018 Aug; 89(8):808-812. PubMed ID: 29353237
[TBL] [Abstract][Full Text] [Related]
34. Pathogenesis and molecular targeted therapy of spinal and bulbar muscular atrophy.
Adachi H; Waza M; Katsuno M; Tanaka F; Doyu M; Sobue G
Neuropathol Appl Neurobiol; 2007 Apr; 33(2):135-51. PubMed ID: 17359355
[TBL] [Abstract][Full Text] [Related]
35. X-linked spinal and bulbar muscular atrophy (Kennedy's disease): the first case described in the Brazilian Amazon.
Alves CN; Braga TKK; Somensi DN; Nascimento BSVD; Lima JAS; Fujihara S
Einstein (Sao Paulo); 2018 Jun; 16(2):eRC4011. PubMed ID: 29898093
[TBL] [Abstract][Full Text] [Related]
36. Kennedy's disease: pathogenesis and clinical approaches.
Greenland KJ; Zajac JD
Intern Med J; 2004 May; 34(5):279-86. PubMed ID: 15151675
[TBL] [Abstract][Full Text] [Related]
37. Defective excitation-contraction coupling and mitochondrial respiration precede mitochondrial Ca
Marchioretti C; Zanetti G; Pirazzini M; Gherardi G; Nogara L; Andreotti R; Martini P; Marcucci L; Canato M; Nath SR; Zuccaro E; Chivet M; Mammucari C; Pacifici M; Raffaello A; Rizzuto R; Mattarei A; Desbats MA; Salviati L; Megighian A; Sorarù G; Pegoraro E; Belluzzi E; Pozzuoli A; Biz C; Ruggieri P; Romualdi C; Lieberman AP; Babu GJ; Sandri M; Blaauw B; Basso M; Pennuto M
Nat Commun; 2023 Feb; 14(1):602. PubMed ID: 36746942
[TBL] [Abstract][Full Text] [Related]
38. Leuprorelin rescues polyglutamine-dependent phenotypes in a transgenic mouse model of spinal and bulbar muscular atrophy.
Katsuno M; Adachi H; Doyu M; Minamiyama M; Sang C; Kobayashi Y; Inukai A; Sobue G
Nat Med; 2003 Jun; 9(6):768-73. PubMed ID: 12754502
[TBL] [Abstract][Full Text] [Related]
39. Phenotypic and molecular features underlying neurodegeneration of motor neurons derived from spinal and bulbar muscular atrophy patients.
Sheila M; Narayanan G; Ma S; Tam WL; Chai J; Stanton LW
Neurobiol Dis; 2019 Apr; 124():1-13. PubMed ID: 30391288
[TBL] [Abstract][Full Text] [Related]
40. Muscle BDNF improves synaptic and contractile muscle strength in Kennedy's disease mice in a muscle-type specific manner.
Halievski K; Xu Y; Haddad YW; Tang YP; Yamada S; Katsuno M; Adachi H; Sobue G; Breedlove SM; Jordan CL
J Physiol; 2020 Jul; 598(13):2719-2739. PubMed ID: 32306402
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
